Ihssane Bouybayoune
Overview
Explore the profile of Ihssane Bouybayoune including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
149
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gosling S, Arnold E, Davies S, Cross H, Bouybayoune I, Calabrese D, et al.
Sci Rep
. 2023 Jun;
13(1):9331.
PMID: 37291276
Ductal carcinoma in-situ (DCIS) accounts for 20-25% of all new breast cancer diagnoses. DCIS has an uncertain risk of progression to invasive breast cancer and a lack of predictive biomarkers...
2.
Bouzy P, Lyburn I, Pinder S, Scott R, Mansfield J, Moger J, et al.
Anal Methods
. 2023 Mar;
15(13):1620-1630.
PMID: 36880909
Microcalcifications play an important role in cancer detection. They are evaluated by their radiological and histological characteristics but it is challenging to find a link between their morphology, their composition...
3.
Opzoomer J, Anstee J, Dean I, Hill E, Bouybayoune I, Caron J, et al.
Sci Adv
. 2021 Nov;
7(45):eabg9518.
PMID: 34730997
Tumor-associated macrophages (TAMs) are a highly plastic stromal cell type that support cancer progression. Using single-cell RNA sequencing of TAMs from a spontaneous murine model of mammary adenocarcinoma (), we...
4.
Vinsland E, Baskaran P, Mihaylov S, Hobbs C, Wood H, Bouybayoune I, et al.
Sci Rep
. 2021 Aug;
11(1):16299.
PMID: 34381067
Correct orchestration of nervous system development is a profound challenge that involves coordination of complex molecular and cellular processes. Mechanistic target of rapamycin (mTOR) signaling is a key regulator of...
5.
Lavigna G, Masone A, Bouybayoune I, Bertani I, Lucchetti J, Gobbi M, et al.
Neurobiol Dis
. 2021 Aug;
158:105455.
PMID: 34358614
Fatal familial insomnia (FFI) is a dominantly inherited prion disease linked to the D178N mutation in the gene encoding the prion protein (PrP). Symptoms, including insomnia, memory loss and motor...
6.
van Seijen M, Jozwiak K, Pinder S, Hall A, Krishnamurthy S, Thomas J, et al.
J Pathol Clin Res
. 2021 Feb;
7(3):233-242.
PMID: 33620141
The prognostic value of cytonuclear grade in ductal carcinoma in situ (DCIS) is debated, partly due to high interobserver variability and the use of multiple guidelines. The aim of this...
7.
Beatson R, Graham R, Grundland Freile F, Cozzetto D, Kannambath S, Pfeifer E, et al.
Commun Biol
. 2020 Nov;
3(1):644.
PMID: 33149188
The tumour microenvironment plays a crucial role in the growth and progression of cancer, and the presence of tumour-associated macrophages (TAMs) is associated with poor prognosis. Recent studies have demonstrated...
8.
Bouybayoune I, Comerio L, Pasetto L, Bertani I, Bonetto V, Chiesa R
Neurobiol Dis
. 2019 Jun;
130:104498.
PMID: 31181281
Prion diseases typically involve brain deposition of abnormally folded prion protein, which is associated with activated glia and increased cytokine production. Cyclophilin A (CypA) is a ubiquitous protein with peptidyl...
9.
Bouybayoune I, Mantovani S, Del Gallo F, Bertani I, Restelli E, Comerio L, et al.
PLoS Pathog
. 2015 Apr;
11(4):e1004796.
PMID: 25880443
Fatal familial insomnia (FFI) and a genetic form of Creutzfeldt-Jakob disease (CJD178) are clinically different prion disorders linked to the D178N prion protein (PrP) mutation. The disease phenotype is determined...
10.
Polito L, Chierchia A, Tunesi M, Bouybayoune I, Kehoe P, Albani D, et al.
J Alzheimers Dis
. 2014 Jun;
42(3):851-64.
PMID: 24961946
Environmental enrichment (EE) is a non-pharmacological intervention reported to counteract pathological signs in models of Alzheimer's disease (AD). We developed EE protocols in APP23 mice and evaluated how they influenced...